Bottom line: Among all the peptides we work with, GHK-Cu has one of the mildest side effect profiles
We stand behind our process and will work with you to resolve any concerns
Since the approval of exenatide in 2005, the GLP-1 RA class has expanded to include liraglutide, semaglutide, dulaglutide, and lixisenatide, each differing in half-life, route of administration, and molecular structure (Arak et al., 2015)
The most important thing is that you take them consistently every day
GLP-1 peptides like cagrilintide and semaglutide are extremely potent at small doses, so some researchers use as little as 0.5-1 mL for these compounds
Abstract PUMILIO/FBF (PUF) proteins have a conserved function in stem cell regulation